From the Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China (Z.H., X.X., C.C., H.L., D.W.W.).
Hubei Key Laboratory of Genetics and Molecular Mechanism of Cardiological Disorders, Wuhan, China (Z.H., X.X., C.C., H.L., D.W.W.).
Hypertension. 2020 Jan;75(1):119-130. doi: 10.1161/HYPERTENSIONAHA.119.13709. Epub 2019 Dec 2.
The AR (adenosine 2A receptor) plays a crucial role in the pathophysiological process of cardiovascular diseases, yet its effect on aortic remodeling remains unclear. We observed elevated adenosine and AR levels following infusion of mice with Ang II (angiotensin II), suggesting a potential role for the adenosine-AR system in macrophage accumulation and subsequent aortic remodeling. The effects and mechanisms of AR on macrophage dynamics during aortic remodeling were further investigated using mice with macrophage knockout of AR and by transplantation of AR bone marrow. We demonstrated that macrophage knockout of AR inhibited macrophage accumulation and subsequent aortic remodeling by inhibiting macrophage retention. This was shown to occur via promotion of macrophage emigration to the draining lymph node. These effects correlated with restoration of the expression and surface content of CCR7 (CC chemokine receptor 7). Consistently, AR bone marrow transplantation relieved Ang II-induced aortic remodeling, macrophage retention, and CCR7 downregulation and internalization, all of which were rescued by AR/ bone marrow transplantation. In addition, CCR7 antibody treatment blocked all the protective effects observed in AR-cKO mice, including attenuation of aortic remodeling and decreased macrophage retention. In in vitro studies, AR activation induced by Ang II suppressed macrophage migration to CCL19 (CC-chemokine ligand) 19 through downregulation and internalization of CCR7. In summary, AR activation contributes to Ang II-induced macrophage retention and subsequent aortic remodeling by inhibiting migration of macrophages to the draining lymph node through regulating CCR7 expression and internalization.
腺苷 A2A 受体(AR)在心血管疾病的病理生理过程中起着至关重要的作用,但它对主动脉重塑的影响尚不清楚。我们观察到在 Ang II(血管紧张素 II)输注后,腺苷和 AR 水平升高,这表明腺苷-AR 系统在巨噬细胞积累和随后的主动脉重塑中可能发挥作用。我们使用 AR 敲除巨噬细胞的小鼠和 AR 骨髓移植进一步研究了 AR 对主动脉重塑期间巨噬细胞动态的影响。我们证明,AR 敲除抑制了巨噬细胞的积累和随后的主动脉重塑,从而抑制了巨噬细胞的保留。这是通过促进巨噬细胞向引流淋巴结的迁移来实现的。这些作用与 CCR7(CC 趋化因子受体 7)的表达和表面含量的恢复相关。一致地,AR 骨髓移植缓解了 Ang II 诱导的主动脉重塑、巨噬细胞保留和 CCR7 下调和内化,所有这些都通过 AR/骨髓移植得到挽救。此外,CCR7 抗体治疗阻断了 AR-cKO 小鼠观察到的所有保护作用,包括主动脉重塑的减弱和巨噬细胞保留的减少。在体外研究中,Ang II 诱导的 AR 激活通过下调和内化 CCR7 抑制了巨噬细胞向 CCL19(CC 趋化因子配体 19)的迁移。总之,AR 激活通过调节 CCR7 的表达和内化,抑制巨噬细胞向引流淋巴结的迁移,促进 Ang II 诱导的巨噬细胞保留和随后的主动脉重塑。